News

The increasing demand for rigorous testing of medical devices is fueling significant growth in the Medical Device Analytical Testing Outsourcing Market. This sector is expected to grow from USD 5.84 billion in 2024 to USD 10.86 billion by 2034, maintaining a steady Compound Annual Growth Rate (CAGR) of 6.4% over the forecast period.

Key factors driving this market include product complexity, heightened competition, an increase in the number of small-scale medical device manufacturers, and stringent approval regulations. The COVID-19 pandemic underscored the need for innovative, low-cost medical equipment, leading to economic and health challenges worldwide. Consequently, many businesses have shut down factories and halted most manufacturing processes.

The rising global prevalence of chronic diseases is increasing the demand for medical device analytical testing outsourcing. Stricter government quality certification rules are propelling the global market forward. Class II devices require premarket approvals and 510(k) clearance, which is a time-consuming process. This scenario has boosted the growth of the global medical device analytical testing outsourcing market. Medical device manufacturers are increasingly hiring consultants to navigate the documentation and regulations necessary for pre-market approvals.

The development of advanced devices, such as surgical microscopes, surgical robots, neurosurgery devices, and ophthalmic surgical devices, has reduced human contact during surgical procedures, making quality certificates for medical devices mandatory. The growing demand for minimally invasive surgeries is further driving the market. Manufacturers are turning to medical device analytical testing outsourcing to ensure accuracy, precision, quality control, and periodic maintenance.

Medical Device Analytical Testing Outsourcing Market Key Takeaways:

– The global Medical Device Analytical Testing Outsourcing market is projected to reach USD 10.96 billion during the forecast period.

– In 2021, the global market was valued at USD 5.11 billion.
– The U.S. is expected to lead the market, reaching USD 1.5 billion and expanding at a CAGR of 7% during the forecast period.

– China is anticipated to grow at a CAGR of 5.5%.

– The hospitals segment is predicted to lead the market with a CAGR of 6.15% during the assessment period.

Source: Future Market Insights